U. Dua

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

R. Khanna, Corey Smith, M. Gandhi, 2007, Blood.

Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma

J. Burrows, R. Khanna, M. Gandhi, 2006, Clinical Cancer Research.

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis

M. Gandhi, D. Gill, C. Cheung, 2008, Nature Clinical Practice Oncology.

Immunity, Homing and Efficacy of Allogeneic Adoptive Immunotherapy for Posttransplant Lymphoproliferative Disorders

M. Gandhi, D. Gill, D. Crawford, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

R. Khanna, Corey Smith, M. Gandhi, 2006, Blood.

Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma

M. Gandhi, A. Grigg, U. Dua, 2006, Leukemia & lymphoma.

Fulminant infectious mononucleosis and recurrent Epstein-Barr virus reactivation in an adolescent.

M. Gandhi, J. Nourse, G. Kennedy, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epstein–Barr virus T‐cell immunity despite rituximab

R. Khanna, D. Moss, M. Gandhi, 2007, British journal of haematology.